The reduction in the price target from $42 to $37 by a reputable analyst firm like Cantor Fitzgerald could lead to a negative short-term sentiment among investors, potentially causing a decrease in ACAD's stock price. The maintenance of an Overweight rating indicates a positive outlook on the company's fundamentals, but the lowered price target may overshadow this optimism in the short term.